Making good on a threat, Ohio Attorney General Dave Yost filed a lawsuit against OptumRx, the pharmacy benefits manager, for allegedly overcharging $16 million to a state agency for generic drugs.

Specifically, Yost contended that OptumRx, which is owned by UnitedHealth Group (UNH), the big insurer, failed to pass along discounts for medicines that were purchased by the Ohio Bureau of Workers’ Compensation between 2015 and 2018. He first raised the allegation in a Feb. 11 letter to the PBM in which the overcharges are a “matter of considerable public significance.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy